SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending due to its recent selection by the US Department of Commerce to publish official macroeconomic data on-chain, solidifying its position as a critical oracle provider. The community is actively discussing PYTH's potential as a 'government-vetted' project within the Real World Asset (RWA) narrative, often comparing its long-term prospects favorably against other oracle solutions.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently trending due to securing an $816 million prime contract from the U.S. Space Force to develop and manufacture 18 missile defense satellites, with potential for total contract value up to $1 billion. The community is highly bullish, celebrating this as a transformative win that solidifies RKLB's role as a vertically integrated defense-space manufacturer. This major contract, alongside discussions of the broader space economy, is driving significant investor conversation and enthusiasm for the company's future.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

Newegg is trending amidst significant insider buying from Vladimir Galkin, who is rapidly consolidating ownership, and recent business developments like its PayPal AI integration and SHEIN marketplace launch. The community is intensely focused on the stock's extremely low free float and allegations of market manipulation, spurring widespread talk of an impending short squeeze. Many investors remain committed, viewing current price movements as attempts by short sellers to control the narrative before a substantial upward move.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending with significant momentum following an analyst upgrade and heightened anticipation for the imminent NASA Lunar Terrain Vehicle (LTV) contract award. The community is actively debating recent insider share sales, which bulls largely view as routine pre-planned transactions amidst considerable short interest. This activity positions LUNR as a focal point within the accelerating space exploration sector.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network (ZBCN) is trending as the crypto community eagerly anticipates confirmed ISO 20022 compliance and the launch of its Super App, which are seen as critical catalysts. Recent significant partnerships with Dash, NatPay, and Fasset, integrating Zebec's real-time payment rails into traditional finance, are driving strong bullish sentiment and accumulation despite current price action.

A fun meme coin with no utility beyond spreading Christmas cheer. X is exploding with people changing their profile pictures to include a Santa Hat, we are taking advantage of the hype and launched the perfect token for it. Beyond that, there is no function. Just spreading joy this season. Elon Musk himself changed his profile picture. The coin is run by one of the biggest influencers on X No utility, run purely on hype and memes

SANTA HAT

SANTAHAT CRYPTO is gaining traction, driven by its festive meme appeal and speculative interest within the crypto community. Traders are actively discussing its potential for a significant upward move, with many hoping this holiday-themed token will "go to the moon." This widespread conversation highlights the speculative enthusiasm often seen around meme coins during seasonal periods.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending following news of its merger with nuclear fusion company TAE Technologies, sparking fervent discussion. Supporters view this unexpected pivot into the energy sector as a visionary move with potential for significant growth, especially in powering AI infrastructure. Conversely, many skeptics express concerns about dilution and the highly speculative nature of commercial fusion, questioning the long-term viability and profitability of this ambitious venture.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending amid discussions surrounding potential government pressure on healthcare costs, stemming from political rhetoric and anticipated executive meetings focused on insurer profits. The community is sharply divided, with some anticipating significant downside from regulatory actions and the expiration of ACA subsidies, while others foresee a strategic resolution that could ultimately benefit the sector as a long-term holding.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is experiencing significant volatility amid heightened market apprehension around increased robotaxi competition from Waymo and Tesla, compounded by an expanded FTC lawsuit concerning its Uber One subscription program. Despite this pullback, many investors view the sharp decline as an "overdone" market reaction, highlighting Uber's vast global user base and strategic autonomous vehicle partnerships as strong long-term fundamentals.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is trending due to its recent notable resilience and gains amidst broader market downturns, driven by news of becoming the first major blockchain with an integration-ready post-quantum vault. The community is actively discussing its long-term viability, with proponents highlighting its year-to-date outperformance compared to Bitcoin and its foundational vision for peer-to-peer electronic cash, while skeptics remain vocal about its sustained growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioMarin Pharmaceutical (NASDAQ:BMRN) Shares Gap Up - Here's Why

BioMarin Pharmaceutical (NASDAQ:BMRN) Shares Gap Up - Here's What Happened...

Stock Traders Buy High Volume of Call Options on BioMarin Pharmaceutical (NASDAQ:BMRN)

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) was the recipient of unusually large options trading on Friday. Stock investors acquired 3,079 call options on the company. This is an...

<ul class="summary-bullets"><li>The deal values Amicus at $14.50 per share, representing a 33% premium to its $10.90 closing price on Thursday.</li><li>Amicus settled its patent dispute with Indian drugmakers Aurobindo Pharma and Lupin over proposed generic versions of Galafold.</li><li>BioMarin plans to fund the acquisition with a mix of existing cash and about $3.7 billion in new debt</li></ul>Amicus Therapeutics (FOLD) shares jumped more than 30% in on Friday, to their highest level since January 2024, after BioMarin Pharmaceutical (BMRN) agreed to acquire the company in a $4.8 billion all-cash deal.The deal values Amicus at $14.50 per share, representing a 33% premium to its $10.90 closing price on Thursday. The transaction is expected to close in the second quarter of fiscal 2026. Biomarin shares gained 6.6%.Both <a href="https://stocktwits.com/symbol/FOLD">FOLD</a> and <a href="https://stocktwits.com/symbol/BMRN">BMRN</a> were among the top trending tickers on Stocktwits.<h2 class="st-heading-2">Portfolio Expansion And Revenue Pipeline</h2>The acquisition will expand BioMarin’s portfolio, adding two new treatments to its existing medicines for rare inherited metabolic disorders.Galafold for Fabry disease and Pombiliti + Opfolda for Pompe disease generated $599 million in combined net revenues over the past four quarters. U.S. exclusivity for Galafold is projected through January 2037 following recent patent settlements.The deal is expected to boost revenue as soon as it closes and add to earnings within the first year. BioMarin expects the acquisition to become meaningfully more accretive from 2027.The company plans to fund the acquisition with a mix of existing cash and about $3.7 billion in new debt, with Morgan Stanley providing a bridge financing commitment.<h2 class="st-heading-2">IP Dispute Update</h2>Separately, Amicus settled its patent dispute with Indian drugmakers Aurobindo Pharma and Lupin over proposed generic versions of Galafold. Under the agreements, the companies will be allowed to launch generics in the U.S. starting January 30, 2037, subject to FDA approval.As part of the settlement, all ongoing Hatch-Waxman litigation between the parties will be terminated, and U.S. antitrust authorities will review the agreements.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for Biomarin on Stocktwits turned ‘extremely bullish’ from ‘bullish’ a day earlier, amid ‘high' message volumes.&nbsp;<figure class="image"><img style="aspect-ratio:904/100;" src="https://news.stocktwits-cdn.com/BMRN_png_a8236939f5.webp" alt="BMRN.png" width="904" height="100"><figcaption>BMRN's Sentiment Meter And Message Volumes at Premarket on Dec. 18, 2025 | Source: Stocktwits</figcaption></figure>One user highlighted the visibility of BMRN’s FY2027 revenue target.<stembedurl>https://stocktwits.com/DairyQueen505/message/639674012</stembedurl>Retail sentiment for Amicus on the platform remained in the ‘extremely bullish’ zone over the past 24 hours, amid ‘extremely high message volumes.<figure class="image"><img style="aspect-ratio:922/99;" src="https://news.stocktwits-cdn.com/fold_png_a408903f4b.webp" alt="fold.png" width="922" height="99"><figcaption>FOLD's Sentiment Meter and Message Volumes at Premarket on Dec. 18, 2025 | Source: Stocktwits</figcaption></figure>Year-to-date, FOLD stock has gained 15% while BMRN has declined over 20%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/this-new-product-launch-is-lifting-amesite-shares-premarket/cLeiw0iREs7">This New Product Launch Is Lifting Amesite Shares Premarket — Here’s What Investors Are Watching</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

Amicus Stock Surges To Near 2-Year Highs On BioMarin's $4.8B Buyout Deal

The acquisition will add two new treatments to BioMarin’s existing medicines for rare inherited metabolic disorders.

Equity

BioMarin To Acquire Amicus Therapeutics For Around $4.8 Bln

(RTTNews) - BioMarin Pharmaceutical Inc. (BMRN), a pharmaceutical company, Friday announced that it has entered into a definitive agreement to acquire Amicus Therapeutics (FOLD), a biotech company...

BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook

BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook BioMarin to Acquire Amicus...

Do Options Traders Know Something About BMRN Stock We Don't?

Investors need to pay close attention to BioMarin Pharmaceutical stock based on the movements in the options market lately.

Hudson Bay Capital Management LP Sells 60,425 Shares of BioMarin Pharmaceutical Inc. $BMRN

Hudson Bay Capital Management LP decreased its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 10.3% in the second quarter, according to its most recent Form 13F filing with...

BioMarin Pharmaceutical Inc. $BMRN Holdings Lowered by Hudson Bay Capital Management LP

Hudson Bay Capital Management LP cut its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 10.3% in the 2nd quarter, according to its most recent Form 13F filing with the...

Boone Capital Management LLC Has $24.60 Million Position in BioMarin Pharmaceutical Inc. $BMRN

Boone Capital Management LLC lifted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 36.7% in the 2nd quarter, according to the company in its most recent Form...

Bellevue Group AG Lowers Stake in BioMarin Pharmaceutical Inc. $BMRN

Bellevue Group AG cut its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 58.9% during the second quarter, according to its most recent 13F filing with the Securities and...

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

BMRN
Biomarin Pharmaceutical Inc. - Registered Shares

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BMRN News

BMRNBiomarin Pharmaceutical Inc. - Registered Shares